Recombinant factor VIIa and thromboembolic events

JAMA. 2006 Jul 5;296(1):43-4; author reply 44. doi: 10.1001/jama.296.1.43-b.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants
  • Blood Coagulation Disorders
  • Factor VII / adverse effects*
  • Factor VIIa
  • Humans
  • Recombinant Proteins / adverse effects
  • Risk
  • Thromboembolism / chemically induced*

Substances

  • Anticoagulants
  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa